Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-29 01:35:22 - browse：44762

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Chronically ill young patients struggle to find fertility info

hotspot

WSS

Chronically ill young patients struggle to find fertility info

Study: Why relieving medical debt did not improve financial outcomes

California wildfire smoke linked to 52,000 early deaths, study says

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Health care court cases: Humana, Sutter, Novant

Morgan Health, with ambitious aims, wants you to know it’s still here

focus

Wikipedia

entertainment

The high cost of giving birth even with insurance

The biotech scorecard for Q1: 17 stock

At least 13 dead in Texas as scorching temps continue

Cigna wins case to block Amy Bricker's move to CVS

Anesthesiologist group: stop taking Ozempic before surgery

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Dobbs anniversary: the lost opportunity of abortion as health care

Curing rare childhood diseases will falter unless Congress steps up

Bright Health sells Medicare Advantage business to Molina

J&J to buy cancer drug developer Ambrx Biopharma

leisure time

The biotech scorecard for Q1: 17 stock

3 trends to watch in health tech's hiring outlook for 2024

5 takeaways from STAT's examination of Zynex Medical

J&J to buy cancer drug developer Ambrx Biopharma

Federal weight loss drug coverage is 30 years out of date

Teladoc has a new CEO, but challenges remain the same

hotspot

hotspot

hotspot

entertainment